31 related articles for article (PubMed ID: 35459967)
1. Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients.
Lin HC; Jeng WJ; Liu J; Pan MH; Lee MH; Batrla-Utermann R; Lu SN; Chen CF; Yang HI; Chen CJ
Aliment Pharmacol Ther; 2024 Apr; 59(8):993-1002. PubMed ID: 38410882
[TBL] [Abstract][Full Text] [Related]
2. Natural History and Hepatitis B Virus Surface Antigen (HBsAg) Spontaneous Seroclearance in Hepatitis B Virus e-Antigen (HBeAg)-Negative Patients with Inactive Chronic Infection: A Multicenter Regional Study from South Italy.
Barone M; Iannone A; Mezzapesa M; Milella M; Di Gennaro F; Niro G; Cotugno R; Cozzolongo R; Mennea G; Rendina M; Di Leo A
Pathogens; 2023 Sep; 12(10):. PubMed ID: 37887714
[TBL] [Abstract][Full Text] [Related]
3. Sex-differences in the association of interleukin-10 and interleukin-12 variants with the progression of hepatitis B virus infection in Caucasians.
Fischer J; Koukoulioti E; Müller T; Heyne R; Eslam M; George J; Finkelmeier F; Waidmann O; Berg T; van Bömmel F
Hepatol Res; 2023 Dec; 53(12):1156-1168. PubMed ID: 37565510
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus e antigen induces atypical metabolism and differentially regulates programmed cell deaths of macrophages.
Li Y; Wu C; Lee J; Ning Q; Lim J; Eoh H; Wang S; Hurrell BP; Akbari O; Ou JJ
PLoS Pathog; 2024 Mar; 20(3):e1012079. PubMed ID: 38466743
[TBL] [Abstract][Full Text] [Related]
5. Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B Patients.
Ou M; Zhang W; Zhang W; Guo J; Huang R; Wang J; Liu J; Xia J; Wu C; Zhu Y; Chen Y
ACS Omega; 2024 Apr; 9(14):16716-16724. PubMed ID: 38617617
[No Abstract] [Full Text] [Related]
6. Reply: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of Patients with HBeAg-Positive.
Choi WM; Lim YS
Hepatology; 2024 Apr; ():. PubMed ID: 38607785
[No Abstract] [Full Text] [Related]
7. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients.
Luo C
Hepatology; 2024 May; ():. PubMed ID: 38743007
[No Abstract] [Full Text] [Related]
8. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk-A multinational cohort study of HBeAg-positive patients.
He T; Zhang D
Hepatology; 2024 Apr; ():. PubMed ID: 38607724
[No Abstract] [Full Text] [Related]
9. Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics.
Hu JL; Huang AL
Virol Sin; 2024 Feb; 39(1):9-23. PubMed ID: 38110037
[TBL] [Abstract][Full Text] [Related]
10. CD4
Li X; Xu L; Lu L; Liu X; Yang Y; Wu Y; Han Y; Li X; Li Y; Song X; Cao W; Li T
Front Cell Infect Microbiol; 2023; 13():1178788. PubMed ID: 37207191
[TBL] [Abstract][Full Text] [Related]
11. A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.
Liu J; Lee MH; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; Wang LY; You SL; Hsiao CK; Yang HI; Chen CJ
J Hepatol; 2013 May; 58(5):853-60. PubMed ID: 23246508
[TBL] [Abstract][Full Text] [Related]
12. Natural history of chronic hepatitis B REVEALed.
Chen CJ; Yang HI
J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
[TBL] [Abstract][Full Text] [Related]
13. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble programmed death-1 levels predict the spontaneous HBeAg seroclearance in chronic hepatitis B.
Chu YJ; Jeng WJ; Pan MH; Hu HH; Luo WS; Su CY; Chiang CT; Jen CL; Chen CJ; Yang HI
J Gastroenterol; 2022 Jun; 57(6):423-432. PubMed ID: 35459967
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B.
Hu HH; Jeng WJ; Pan MH; Luo WS; Chang CL; Huang YT; Su CY; Chiang CT; Jen CL; Chien YC; Lu SN; Wang LY; Huang LR; Lee MH; Liu J; Nguyen MH; Chen CJ; Yang HI
Aliment Pharmacol Ther; 2022 Mar; 55(5):558-567. PubMed ID: 35032052
[TBL] [Abstract][Full Text] [Related]
16. Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B.
Yang HI; Hung HL; Lee MH; Liu J; Jen CL; Su J; Wang LY; Lu SN; You SL; Iloeje UH; Chen CJ;
Clin Gastroenterol Hepatol; 2012 May; 10(5):527-34.e1-2. PubMed ID: 22178461
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
